Q1 2019 Champions Oncology Inc Earnings Call
שיחת ועידה Champions Oncology Inc
Champions Oncology Inc Conference call will be held on 13/09/2018. During the earnings conference call's session Champions Oncology Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Champions Oncology Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. Utilizing our TumorGraft Technology Platform, we provide select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. By performing studies to predict the efficacy of oncology drugs, our Platform facilitates drug discovery with lower costs and increased speed of drug development as well as increased adoption of existing drugs. The current oncology drug development paradigm is challenging for the pharmaceutical and biotechnology industry. We believe that on average, the clinical trial process in oncology currently: * costs more than $1.2 billion; * takes approximately 8 years to complete; * has a 93% failure rate; and * results in approved compounds that cost more than $11,000 per month.קרא עוד שיחת ועידה